Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Public Storage. | PSA | Oct 31, 2024 | 329.06 | -2.02 |
PubMatic A | PUBM | Oct 31, 2024 | 14.71 | -3.32 |
Pulmatrix | PULM | Oct 31, 2024 | 2.20 | +0.92 |
Pulmonx | LUNG | Oct 31, 2024 | 6.25 | -7.95 |
Pulse Biosciences | PLSE | Oct 31, 2024 | 17.43 | -1.64 |
PulteGroup | PHM | Oct 31, 2024 | 129.53 | -0.56 |
Puma Biotechnology | PBYI | Oct 31, 2024 | 2.85 | +0.35 |
Pure Cycle | PCYO | Oct 31, 2024 | 10.52 | -0.66 |
Pure Storage A | PSTG | Oct 31, 2024 | 50.05 | -6.29 |
PureCycle Technologies | PCT | Oct 31, 2024 | 13.02 | -3.41 |
PureCycle Technologies Unit | PCTTU | Oct 31, 2024 | 17.12 | 0.00 |
Purefunds ISE Junior Silver [Sm | SILJ | Oct 31, 2024 | 13.77 | -3.77 |
PureTech Health ADR | PRTC | Oct 31, 2024 | 20.35 | -2.35 |
Purple Biotech ADR | PPBT | Oct 31, 2024 | 3.21 | -2.73 |
Purple Innovation | PRPL | Oct 31, 2024 | 0.89 | -0.22 |
Putnam Managed Municipal Income Trust | PMM | Oct 31, 2024 | 6.28 | +0.32 |
Putnam Master Intermediate Income Trust | PIM | Oct 31, 2024 | 3.28 | 0.00 |
Putnam Municipal Opportunities Trust | PMO | Oct 31, 2024 | 10.49 | -0.19 |
Putnam Premier Income Trust | PPT | Oct 31, 2024 | 3.59 | -0.28 |
PVH | PVH | Oct 31, 2024 | 98.46 | -0.35 |
Pyrophyte Acquisition | PHYT | Oct 31, 2024 | 11.55 | 0.00 |
Pyxis Oncology | PYXS | Oct 31, 2024 | 3.56 | -5.57 |
Pyxis Tankers | PXS | Oct 31, 2024 | 4.42 | +1.14 |
Pyxis Tankers Pref | PXSAP | Oct 31, 2024 | 24.97 | 0.00 |
Q2 | QTWO | Oct 31, 2024 | 84.66 | -1.14 |
Q32 Bio | QTTB | Oct 31, 2024 | 47.23 | +1.96 |
QCR | QCRH | Oct 31, 2024 | 79.10 | -2.69 |
QIAGEN | QGEN | Oct 31, 2024 | 42.10 | -0.33 |
Qifu Technology ADR | QFIN | Oct 31, 2024 | 32.81 | -2.47 |
Qilian International | QLI | Oct 31, 2024 | 5.41 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.